236 related articles for article (PubMed ID: 20221393)
1. Role of alcohol metabolism in non-alcoholic steatohepatitis.
Baker SS; Baker RD; Liu W; Nowak NJ; Zhu L
PLoS One; 2010 Mar; 5(3):e9570. PubMed ID: 20221393
[TBL] [Abstract][Full Text] [Related]
2. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
Spahr L; Rubbia-Brandt L; Hadengue A
Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.
Videla LA; Rodrigo R; Orellana M; Fernandez V; Tapia G; Quiñones L; Varela N; Contreras J; Lazarte R; Csendes A; Rojas J; Maluenda F; Burdiles P; Diaz JC; Smok G; Thielemann L; Poniachik J
Clin Sci (Lond); 2004 Mar; 106(3):261-8. PubMed ID: 14556645
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
6. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
7. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
[TBL] [Abstract][Full Text] [Related]
9. [Nonalcoholic steatohepatitis. Three case reports].
Eivindson MV; Hamilton-Dutoit S; Grønbaek H
Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
[TBL] [Abstract][Full Text] [Related]
10. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
13. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
Cortez-Pinto H; Camilo ME
Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Miele L; Forgione A; Gasbarrini G; Grieco A
Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
[TBL] [Abstract][Full Text] [Related]
17. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects.
Rodríguez-Hernández H; Gonzalez JL; Rodríguez-Morán M; Guerrero-Romero F
Arch Med Res; 2005; 36(4):362-6. PubMed ID: 15950075
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
19. Update on non-alcoholic fatty liver disease in children.
Papandreou D; Rousso I; Mavromichalis I
Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
[TBL] [Abstract][Full Text] [Related]
20. Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Feb; 98(2):495-9. PubMed ID: 12591075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
